Colleen Newvine
Family · Broomfield, CONPI 1548869860
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $533 of the $632 with a category attached, or 84.3%. 14 manufacturers reported payments, led by Incyte Corporation at 24.0% of the total.
Across 23 payments — averaging $27.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$152
- Bayer$84
- Johnson & Johnson$69
- Eisai Inc.$68
- Astellas Pharma US Inc$46
- AVEO Pharmaceuticals, Inc.$35
- plus $179 from 8 others
What the payments were for
- Food & beverage$53384%
- Education$9916%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 3 | $152 |
| Bayer | 3 | $84 |
| Johnson & Johnson | 3 | $69 |
| Eisai Inc. | 3 | $68 |
| Astellas Pharma US Inc | 2 | $46 |
| AVEO Pharmaceuticals, Inc. | 1 | $35 |
| Genmab U.S., Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $29 |
| Gilead | 1 | $26 |
| Pfizer | 1 | $23 |
| Sobi, Inc | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Novartis | 1 | $16 |
| Novocure Inc. | 1 | $14 |
How this compares
$632 in reported general payments places this provider in the 70th percentile of 2,182 family providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 18 | $278 |
Paid to pharmacies, not to this prescriber.
Other family in Broomfield
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- April RossGrand Junction$95K
- Jeannette LillerColorado Springs$74K
- Teal MeffordThornton$63K
- Jacquita JordanColorado Springs$52K
- Stephanie HanenbergColorado Springs$40K
- Courtney WeirFort Collins$30K
- Katie NadingDenver$28K
- Randall McDavidDenver$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.